CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
BMR Facedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01740440
NCT01740440Phase 4Completed
CompareCT.gov

Effect of a Transcutaneous Electrical Nerve Stimulation (TENS) Device on Overall Facial Appearance

Bio-Medical Research, Ltd.·interventional·Posted Dec 4, 2012·Updated Jun 30, 2016

In Brief

A Phase 4 clinical trial evaluating BMR Face for Ageing. Completed, enrolled 30 participants across 1 site.

Detailed Summary

Safety and clinical performance of the BMR Face device (manufactured by Bio-Medical Research)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAgeing
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedDec 4, 2012
Enrollment StartNov 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.6 years ago

Interventions

BMR Facedevice

BMR Face used in accordance with manufacturer IFU